PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.\', \'Radboudumc Center for Infectious Diseases, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.\', \'Department of Medicine, University of Cambridge, Cambridge, CB20 QQ, UK.\', \'Department of Intensive Care Medicine, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.\', \'Núcleo de Pesquisa da Faculdade da Polícia Militar (FPM) do Estado de Goiás, Goiânia, Goiás, Brasil.\', \'Inotrem, 54500 Vandoeuvre-les-Nancy, France.\', \'Intensive Care Unit, Centre Hospitalier Regional Universitaire (CHRU), 54000 Nancy, France.\', \'Immunology and Metabolism, Life & Medical Sciences Institute, University of Bonn, 53115 Bonn, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • BSR2021094010.1042/BSR20210940
?:hasPublicationType
?:journal
  • Bioscience reports
is ?:pmid of
?:pmid
?:pmid
  • 34195785
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.296
?:rankingScore_hIndex
  • 65
is ?:relation_isRelatedTo_publication of
?:title
  • Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all